Morning Wrap

Today ’s Newsflow Equity Research 19 Jul 2019 08:16 BST Upcoming Events Select headline to navigate to article

Paper and Packaging Stora Enso reports weak Q2, Company Events flagging lower box prices 19-Jul ; Q419 Trading Update Stora Enso ; Q219 Results Building Materials US non-residential forecasts are 23-Jul Paragon Banking; Q319 Trading Update revised down 24-Jul ; Q319 Trading Update Kindred Group; Q219 Results UK Banks CBG issues a disappointing pre-close trading Marston's; Q319 Trading Update Metro Bank; Q219 Results update – NIM in focus 25-Jul AIB Group; Q219 Results Bankinter; Q219 Results Breedon Group; Interim results Howden Joinery; H1 results International Paper; Q219 Results Permanent TSB; Q219 Results Tyman; H1 results Unilever PLC; Q219 Results ; Q120 Results

Economic Events Ireland 22-Jul PPI June19 Wholesale Price Index June19 26-Jul Retail Sales June19

United Kingdom 23-Jul CBI Industrial Trends July19 25-Jul CBI Distributive Trades July19

United States

Europe

This document is intended for the sole use of Goodbody Stockbrokers and its affiliates

Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE

Goodbody Stockbrokers UC, trading as “Goodbody”, is regulated by the Central Bank of Ireland. In the UK, Goodbody is authorised and subject to limited regulation by the Financial Conduct Authority. Goodbody is a member of the Irish Stock Exchange and the Stock Exchange. Goodbody is a member of the FEXCO group of companies. For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate, Goodbody Stockbrokers Goodbody Morning Wrap

Paper and Packaging Stora Enso reports weak Q2, flagging lower box prices

Stora Enso has reported Q2 results to the end of June. At a headline level, group sales and David O’Brien EBIT came in 2% and 7% behind consensus estimates. Additionally, the mid-point of the +353-1-641 9230 group’s guidance for Q3 is 19% below consensus. david.a.o’[email protected]

Robert Eason Of relevance for the three names under our coverage, Packaging Solutions EBIT fell 32% yoy +353-1-641 9271 (-16% Q1), missing estimates by 19%. This was driven by the well-documented drop in [email protected] containerboard pricing, lower containerboard deliveries, offset by slightly stronger demand for corrugated boxes. Of particular note, management has flagged lower sequential pricing of

corrugated boxes, which is the first hard data point seen in the industry of such a fall

through this cycle.

Given the negative trend in containerboard pricing over the last 10 months we were expecting box prices to weaken into H219 so this Q219 data represents confirmation that this trend has begun. As such, we believe DS Smith, Smurfit Kappa, and to a lesser extent Mondi, will struggle to grow earnings organically over the short-term.

Home…

Building Materials US non-residential forecasts are revised down

The American Institute of Architects (publishers of the Architectural Billings Index) released David O’Brien its latest consensus overview of non-residential construction forecasts, which is derived from +353-1-641 9230 a panel of eight industry bodies. For the current year the expectation is for the segment to david.a.o’[email protected] grow by 3.8%, down 60bps from the last forecast in January, with the key driver being the Robert Eason commercial segment where growth was revised down by 100bps to 2.5%. Industrial is +353-1-641 9271 expected to grow by 6.4% and Institutional +4.9%. [email protected]

Forecasts for next year are unchanged with growth expected to slow to 2.4%. Similar to Sarah Stokes +353-1-641 0482

2019, the commercial segment is expected to have the weakest growth at 1.1%, while This document is intended for the sole use of Goodbody Stockbrokers and its affiliates [email protected] Institutional and Industrial are forecast to grow by 3.7% and 3.3%, respectively.

Sean Blaney Given that the ABI has been soft for most of this year, the downgrade to US non- +353-1-6419222 residential forecasts does not come as a surprise. Indeed, one could argue should [email protected] the revisions have been more, especially for 2020. With this as a backdrop, the US non-residential segment will be a key area of focus in the upcoming results from the building materials sector.

Home…

Page 2 19 Jul. 19 Goodbody Morning Wrap

UK Banks CBG issues a disappointing pre-close trading update – NIM in focus Close Brothers Group (CBG) published a pre-close trading update for the 11-month period to 30th June 2019 this morning ahead of the publication of its full year results for the year ending John Cronin +353-1-641 9187 31st July on 24th September. In overall terms, the company notes that it has “continued to [email protected] perform well across all divisions, consistent with our Q3 trading update”. However, we get

some more meat on questions that surfaced at the stage of the 3Q19 results (Banking Division Colin Jackson NIM, Asset Management profitability) on 22nd May last. +353-1-641 6050 [email protected]

Firstly, CBG notes that the Banking division loan book was +5.1% 11M YTD to £7.3bn at 30th Barry Egan June, which represents a decent improvement on the +3.6% 9M YTD growth at 30th April – a +353-1-641 9492 trend that is consistent with the prior year, where May and June also proved to be important [email protected] months from a loan book expansion perspective. While Commercial was unsurprisingly an

important driver of growth for the 11M period, it is interesting to note that the Property loan book was “broadly flat”. CBG also noted that growth in the Retail loan book was “solid”, mainly driven by Premium Finance with a modest uplift in Motor – CBG did not call out Retail as a source of growth at the 3Q19 results stage and noted strong growth in Premium Finance but slight contraction in Motor in the 1H19 release. Growth in Motor in recent months may raise some concerns regarding margin outlook (see below) and asset quality (we have seen Fleet News report heavy falls in used car prices in recent months). CBG calls out a “slight reduction” in NIM to 7.8% 11M YTD. We were previously told that 3Q19 NIM was “broadly in line” (which raised questions) with FY18 NIM, i.e., 8.0%, though it is important to note that 1H19 NIM was “strong” at 8.1%. The drop from 8.1% to 7.8% implies that CBG’s NIM for the five- month period to 30th June is actually <7.5% (which could be construed as a rebasing of run rate NIM) and we are told that the NIM compression reflects fee income as well as funding cost pressures – any deterioration in asset yields owing to competitive pressures would add to NIM pressure.

On a more positive note, it was reassuring to note that bad debts have, once again, remained low with “continued strong credit performance across the business” – testament to CBG management’s disciplined approach to lending though, as for other lenders, there are of course risks on the horizon.

Secondly, “good net inflows” were recorded in Asset Management, with managed assets +9% 11M YTD to £11.3bn (up from £10.9bn at 30th April) and total client assets +6% 11M YTD to £12.9bn (up from £12.5bn at 30th April), though these growth rates are lower than the growth run rates in the equivalent 11M period to 30th June 2018 (which saw managed assets and

total client assets +14% and +8% 11M YTD respectively). CBG cautions on Asset Management This document is intended for the sole use of Goodbody Stockbrokers and its affiliates profitability, noting that it “continues to reflect lower market levels for the year and ongoing investment spend”. Notably, CBG reported that Asset Management operating profit was -5% y/y in 1H19 in response to challenging market conditions and higher costs (new hires, etc.).

Finally, we got the same positive message on Winterflood as we did at the stage of the 3Q19 trading update, i.e., “solid profitability” though trading volumes “remained low”.

All-in-all CBG reported a decent performance in the 11M YTD period in the face of more challenging market conditions than the prior year. However, the market is unlikely to react warmly to the material NIM compression recorded since 1H19 and is also likely to have some further concerns regarding profitability in Asset Management despite the fact that CBG reported that operating profits in this division were down in 1H19.

Home…

Page 3 19 Jul. 19 Goodbody Morning Wrap

Issuer & Analyst Disclosures

Analyst Certification The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by me in this report.

Regulatory Information Goodbody Stockbrokers UC, trading as “Goodbody”, is regulated by the Central Bank of Ireland. In the UK, Goodbody is authorised and subject to limited regulation by the Financial Conduct Authority. Goodbody is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by Goodbody. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities.

Conflicts of Interest Goodbody has procedures and policies in place to identify and manage any potential conflicts of interest that arise in connection with its research business. Goodbody analysts and other staff who are involved in the preparation and dissemination of research operate and have a management reporting line that is independent to its business. Information barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive information is handled in an appropriate manner.

Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest

Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication, in order to correct factual inaccuracies only and not to materially amend the research in any way. Goodbody is satisfied that it has operational procedures in place, which ensure that such disclosures will not compromise the report’s objectivity.

Goodbody has provided investment banking services to AIB Group, Applegreen, ARYZTA, Cairn Homes, Datalex, Draper Esprit, FBD Holdings, First Derivatives, Flutter Entertainment, , , Hibernia REIT, ICG, IFG Group, IPL Plastics, Kingspan, OneSavings Bank, Origin Enterprises, , Rank Group, Supermarket Income REIT and UDG Healthcare in the past 12 months.

Goodbody Stockbrokers acts as corporate broker to AIB Group, Applegreen, ARYZTA, Cairn Homes, Datalex, Draper Esprit, FBD Holdings, First Derivatives, Flutter Entertainment, Grafton Group, Greencore, Hibernia REIT, ICG, IFG Group, IPL Plastics, Kingspan, Origin Enterprises, Playtech, Rank Group, UDG Healthcare, and Yew Grove REIT The list of companies for which Goodbody acts as market maker and on which it provides research, is available at Regulatory Disclosures

This document is intended for the sole use of Goodbody Stockbrokers and its affiliates

Page 4 19 Jul. 19 Goodbody Morning Wrap

Other disclosures

We would like to inform you that Robert Eason holds shares in Kingspan We would like to inform you that Robert Eason holds shares in SIG

A description of this company is available at Company Descriptions

All prices used in this report are as at close of business of the previous working day unless otherwise indicated.

A summary of our standard valuation methods are available at Valuation Methodologies

A summary of share price recommendations and whether material investment banking services have been provided to these companies is available at Regulatory Disclosures

Other important disclosures are available at Regulatory Disclosures

Goodbody updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody is available at Regulatory Disclosures Where Goodbody has provided investment banking services to an issuer, details of the proportion of buys, holds and sells attributed to that issuer will also be included. This is updated on a quarterly basis.

The date on which stock recommendations were first released for all stocks mentioned in this report are available at https://www.goodbody.ie/assets/Reg_Disclosures.pdf. If a different recommendation has been made in the previous twelve months, this will also be disclosed here.

Recommendation Definitions Goodbody uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than 10% over the next twelve months.

On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the security to decline by up to 15% over the next twelve months.

In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other reason the firm will disclose this fact.

Distribution of research to clients of Goodbody Securities Inc (GSI) in the US

GSI distributes third-party research produced by its affiliate, Goodbody GSI is a member of FINRA and SIPC GSI does not act as a market-maker.

This information was current as of the last business day of the month preceding the date of the report. An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be effected through GSI.

Disclaimer This document is intended for the sole use of Goodbody Stockbrokers and its affiliates While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in substitution for the exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax advice, or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you.

Private customers having access, should not act upon it in anyway but should consult with their independent professional advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value. You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.

All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Goodbody.

Goodbody, Ballsbridge Park, Ballsbridge, Dublin 4, Ireland T (+353 1) 6670400 W www.goodbody.ie E [email protected] Page 5 19 Jul. 19